Approval · Notice of Compliance 34709 · 2025
EYLEA HD: Notice of Compliance 34709
Issued January 20, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34709
- Date
- January 20, 2025
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation and additional manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EYLEA HD | 02554798 | Marketed |
Medicinal ingredients
- AFLIBERCEPT 8 ML per 0.07ML